The 2019 pipeline report: Changing the treatment paradigm

The 2019 pipeline report: Changing the treatment paradigm

Amgen, Entera to Partner on Oral Drugs for Inflammatory Disease, Other “Serious” Illnesses

Amgen, Entera to Partner on Oral Drugs for Inflammatory Disease, Other “Serious” Illnesses